Intent To Grant an Exclusive License of a U.S. Government-Owned Patent

---
identifier: "/us/fr/E7-22963"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Intent To Grant an Exclusive License of a U.S. Government-Owned Patent"
title_number: 0
title_name: "Federal Register"
section_number: "E7-22963"
section_name: "Intent To Grant an Exclusive License of a U.S. Government-Owned Patent"
positive_law: false
currency: "2007-11-26"
last_updated: "2007-11-26"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Defense Department"
document_number: "E7-22963"
document_type: "notice"
publication_date: "2007-11-26"
agencies:
  - "Defense Department"
  - "Army Department"
fr_citation: "72 FR 65947"
fr_volume: 72
fr_action: "Notice."
---


#  Intent To Grant an Exclusive License of a U.S. Government-Owned Patent

**AGENCY:**

Department of the Army, DoD.

**ACTION:**

Notice.

**SUMMARY:**

In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7 (a)(I)(i), announcement is made of the intent to grant an exclusive, royalty-bearing, revocable license to A Live-Attenuated Rift Valley fever virus as a licensed human vaccine to The University of Texas Medical Branch at Galveston, with its principal place of business at 301 University Boulevard, Galveston, TX 77555.

**ADDRESSES:**

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.

**FOR FURTHER INFORMATION CONTACT:**

For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664. For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808, both at telefax (301) 619-5034.

**SUPPLEMENTARY INFORMATION:**

Anyone wishing to object to the grant of this license can file written objections along with supporting evidence, if any, 15 days from the date of this publication. Written objections are to be filed with the Command Judge Advocate (see *ADDRESSES* ).

Brenda S. Bowen,

Army Federal Register Liaison Officer.